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1. Introduction
  Osteonecrosis of the femoral head (ONFH) is one of the 
commonest osteoarthropathies around the world, which 
is primarily the destruction of blood supply of adjacent 
articular surfaces around the femoral head caused by several 
diseases, thus lead to osteonecrosis of the weight-bearing 
areas. The challenge is filling in the defects of osteonecrosis 
area and the recovery of local blood supply[1,2]. Currently, 
one of the most common treatments is surgery and but there 
are many problems such as post-operative complications, 
short life of prosthesis. To find a better treatment for 
osteonecrosis has been the common interest. Poor local 
blood supply of femur head and lack of bone growth factors 
are important causes of ONFH. The recombinant human 
bone morphogenetic protein 2 (rhBMP-2) has higher purity 
than bone morphogenetic protein (BMP). It has potential in 
inducing undifferentiated mesenchymal cells to cartilage 
or osteocyte, but its effectiveness is unsatisfactory because 
drugs cannot continuously stimulate target cells in the 
surrounding defect areas on the basis of its property as 
acidic peptides and short half-life period[3,4]. The present 
research focus is to establish stable rhBMP-2 sustained 
release system and reduce its leakage by loading rhBMP-2 
to the carriers, thus local rhBMP-2 concentrations of 
implant site can be improved and the effectiveness of 
rhBMP-2 can be optimized. Poly-lactide-co-glycolic acid 
Objective: To observe the effect of recombinant human bone morphogenetic protein 2/poly-
lactide-co-glycolic acid (rhBMP-2/PLGA) with core decompression on repair of rabbit femoral 
head necrosis. Methods: Bilateral femoral head necrosis models of rabbit were established by 
steroid injection. A total of 48 rabbits (96 femoral head necrosis) were randomly divided into 4 
groups: Group A, control group with12 rabbits, 24 femoral head necrosis; Group B, treated with 
rhBMP-2/PLGA implantation after core depression, with 12 rabbits, 24 femoral head necrosis; 
Group C, treated with rhBMP-2 implantation after core depression, with 12 rabbits, 24 femoral 
head necrosis; Group D treated with core depression group without implantation, with 12 rabbits, 
24 femoral head necrosis. All animals were sacrificed after 12 weeks. The ability of repairing bone 
defect was evaluated by X-ray radiograph. Bone mineral density analysis of the defect regions 
were used to evaluate the level of ossification. The morphologic change and bone formation 
was assessed by HE staining. The angiogenesis was evaluated by VEGF immunohistochemistry. 
Results: The osteogenetic ability and quality of femoral head necrosis in group B were better 
than those of other groups after 12 weeks by X-ray radiograph and morphologic investigation. 
And the angiogenesis in group B was better than other groups. Group C had similar osteogenetic 
quality of femoral head necrosis and angiogenesis with group D. Conclusions: The treatment of 
rhBMP-2/PLGA implantation after core depression can promote the repair of rabbit femoral head 
necrosis. It is a promising and efficient synthetic bone material to treat the femoral head necrosis.
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(PLGA) featured by low immunity, good biocompatibility 
and regulated degradability is a microsphere matrix, 
where rhBMP-2 loaded microsphere of PLGA has superior 
sustained release properties. In our experiment, the model 
of aseptic necrosis of rabbit femoral head was established 
and rhBMP-2/PLGA sustained release microsphere carrier 
system was injected to bone defect of rabbit femoral head, 
thus its actual possibility of application and availability was 
explored. 
2. Materials and methods
2.1. Experimental animals and major reagents & instruments
  A total of 50 healthy New Zealand white rabbit were 
provided by the Animal Center of Zhejiang University 
Medical College, with average weight of 2.8 kg. rhBMP-2/
PLGA drug-loaded microsphere was generously donated 
by Zhi-Heng Ling, the First Affiliated Hospital of Zhejiang 
University. The entrapment efficiency of PLGA microspheres 
was (37.52依4.31)% and drug loading efficiency was (5.12依
1.32)%[5]. Chitin gel was from Shanghai Qisheng Biological 
Agent Co., Ltd. Methylprednisolone sodium succinate was 
purchased from Nanjing Deepth Chemical Co., Ltd. Horse 
serum was obtained from Guangzhou Rui Special Biological 
Technology Co., Ltd. Ready-to-use immunohistochemical 
ultra-sensitive UltraSensitiveTM SP KIT-9701 and mouse 
anti-human vascular endothelial growth factor (VEGF) 
monoclonal antibody were from Fujian Maixin Biotechnology 
Co., Ltd. Optical microscope (Olympus, Japan). DAKO 
AutostainerPlus Automated Immuno-Histo Stainer (DAKO, 
USA). X-ray apparatus (Radiology Department, the First 
Affiliated Hospital of Medical College, Zhejiang University). 
Microsphere composite was prepared by mixing rhBMP-2/
PLGA and chitin gel together and centrifuged. 3 microgram 
of rhBMP-2 was included in the mixture of gel and 
microsphere per milliliter, which was freshly prepared 
immediately before use. 
2.2. Animal model preparation and randomization
  After adaptive feeding for about one week, 10 mL/kg horse 
serum was firstly injected into the marginal auricular vein of 
rabbits and the same horse serum was injected again three 
weeks later with the amount changed to 6 mL/kg; at a time 
interval of 2 weeks, methylprednisolone sodium succinate 
45 mg/kg was injected into the same site, once daily for 3 
days. Since methylprednisolone sodium succinate injections 
started, each rabbit was intraperitoneally injected with 
penicillin 10 million units/day for continuously 7 days; at the 
last injection, 2 rabbits were sacrificed  randomly to retrieve 
the femoral head  specimens, fixed with 4% formaldehydum 
polymerisatum, decalcified, embedded in paraffin and 
routine HE staining was conducted on serial sections. 
Rabbit modeling was observed by histological methods and 
the criteria for successful modeling in each rabbit were 
avascular necrosis (AVN) of the femoral head. Successful 
modeling rabbits were randomly divided into four groups. 
Group A, blank control group (12 rabbits, 24 sides) without 
treatment after modeling. Group B, rhBMP-2/PLGA group 
(12 rabbits, 24 sides), rhBMP-2/PLGA bearing microsphere 
and chitin gel mixture were injected into orifice after core 
decompression. Group C, rhBMP-2 group (12 rabbits, 24 
sides), rhBMP-2 powder and chitin gel mixture were injected 
into orifice after core decompression. Group D, (12 rabbits, 
24 sides) received only core decompression therapy. The 
bone wax was used to pack small bone cavities and sutured 
of incisions were performed carefully layer by layer after 
intervention in group B, C and D. Routine use of antibiotics 
was carried out after operation.
2.3. X-ray examination
  Anteroposterior view of hip joints obtained by X-ray 
examinations were conducted in animals in each group 
12 weeks after operation. Treatment outcomes of ONFH of 
animals in each group were observed. 
2.4. Histomorphological observation
  The femoral head specimens were retrieved from animals 
in each group 12 weeks after surgery, fixed with 4% 
formaldehydum polymerisatum, decalcified, embedded 
in paraffin and routine HE staining was conducted on 
serial sections. Osteogenesis in the femoral head, material 
degradation, morphological change and bone growth status 
were observed under optical microscope and empty lacunae 
in 5 high-power fields of each specimen were counted. 
2.5. Immunohistochemistry (IHC) evaluation for VEGF 
  The femoral head specimens were obtained as mentioned 
in 1.4,  which was f ixed with 4% formaldehydum 
polymerisatum, decalcified, embedded in paraffin and 
S-P immunohistochemical staining (Ready-to-use 
immunohistochemical ultra-sensitive UltraSensitiveTM SP 
KIT-9701, Fujian Maixin Biotechnology Co., Ltd.) of VEGF 
(mouse anti-human VEGF monoclonal antibody MAB-324, 
Fujian Maixin Biotechnology Co., Ltd.) was conducted on 
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serial sections. Negative control group were treated with PBS 
as primary antibody. VEGF staining was considered positive 
in positive control group. DAB color development (DAB-
1031, Fujian Maixin Biotechnology Co., Ltd.) and hematoxylin 
redyeing was conducted. Image analysis software MetaMorph 
7.6 was adopted. Five randomly-selected fields in 400 times 
microscope field of view were used to observe the average 
optical density. 
2.6. Statistical analysis
  SPSS 13.0 was used in data analysis. All data were 
expressed as mean依standard error. One-way ANOVA was 
used to compare normal distribution data between two 
groups and SNK test was used for pairwise comparisons. 
3. Results
3.1. X-ray results
  12 weeks after operation, X-ray results were obtained. 
A: Blank control group was featured by blurred articular 
surface of rabbit femoral head, unclear bone structure, 
osteosclerosis formation and decreased bone density of 
diaphyseal and metaphyseal regions. B: rhBMP-2/PLGA 
implantation group after core decompression was featured 
by clear articular surface, bone structure approached 
normal group, no osteosclerosis formation and bone density 
closed to normal level. C: rhBMP-2 implantation group after 
core decompression was characterized by slightly blurred 
articular surface, bone structure was much more clear than 
group A, its sclerosis rim was less than group A but more 
than group B and decreased bone density of diaphyseal and 
metaphyseal regions was higher than those of group A. D: 
Core decompression group was featured by slightly blurred 
articular surface, bone structure much more clear than 
group A, its sclerosis rim was less than group A and the bone 
density of diaphyseal and metaphyseal regions was similar 
to those of group C (Figure 1).
A group            B group       C group            D group
  
     
Figure 1. Anteroposterior X-ray film of rabbit femoral head in all 
groups 12 weeks after operation.
3.2. Histological observation 
  Histological observations were conducted on all the groups 
12 weeks after surgery. A: Blank control group, significantly 
thinner cartilaginous layers and plenty of necrotic cartilage 
cells of regular arrangement were observed. Crescent-
shaped defects could be seen in subchondral bone and 
increased numbers of empty bone (19.76依1.02) lacunae than 
those of group B (11.63依1.35), C (14.32依2.01) and D (15.79依
1.42) (P<0.05). Group B: Thickened articular cartilage and 
subchondral bone and regular arrangement of chondrocyte 
were observed. Adipose cells were rarely seen. There was 
much denser distribution of bone trabecular observed, which 
was manifested with fragility. The empty bone lacunae in 
bone trabecular were rare and the number of empty bone 
lacunae in group B was significantly less than those in group 
A, C and D (P<0.05). A large number of osteoblasts were 
surrounding the bone trabecular. Group C: Thinner articular 
cartilage and cartilage cells of irregular arrangement could 
be observed. Subchondral bone was thinner in group C 
compared to group B. Attenuation and partial interruption in 
trabeculae of bone was much more likely than group B. The 
number of empty bone lacunae in bone trabecular was more 
than this in group B, but less than this in group A (P<0.05). 
The number of osteoblasts surrounding the bone trabecular 
decreased. Group D: A few osteoid and new bone trabecular 
were formed around the drilled holes. A few blood vessels 
were formed. The surface layer of articular cartilage of 
group D was similar to group C. The number of empty bone 
lacunae in group D had no significantly differences from this 
of group C (P>0.05) (Figure 2, 3).
 A group            B group      C group      D group
  
Figure 2. Histological observations on rabbit femoral head in all 
groups 12 weeks after operation (HE staining, ×40).
       
A group            B group       C group            D group
Figure 3. Histological observations on rabbit femoral head in all 
groups 12 weeks after operation (HE staining, ×200).
3.3. VEGF staining results
  Particles of VEGF proteins with positive reaction were 
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positioned in cytoplasm of osteocytes and cartilage cells 
(Figure 4). The average optical densities of all the 4 groups 
with positive staining were 0.23依0.12, 0.78依0.09, 0.40依0.11 
and 0.42依0.14, respectively. The optical density of group 
B was significantly higher than those of group A, C and 
D. In addition, the optical density of group C and D were 
significantly higher than the value of group A, while there 
was no significant difference between group C and group D 
(P>0.05).
A group            B group       C group            D group
Figure 4. IHC observations on the local VEGF expression of rabbit 
femoral head in all groups 12 weeks after operation (HE staining, 
×200).
4. Discussion
  Femoral head is important weight-bearing and sports 
parts, which supports the weight of body and bears much 
more physiological stress than any other joints. Once 
ONFH has occurred, joint mobility and walking function 
are gradually lost, accompanied by continuous hip pain. 
ONFH is one of the orthopedics refractory disorders that is 
common in clinical practices. In the early phase of ONFH, 
internal hip joint is in a state of aseptic inflammation 
status without associated infection, where congestive 
exudation, increased intracapsular pressure and femoral 
head ischemia were observed. Besides, there were no 
clear signs of trabeculae fractured, femoral head collapse 
and deformity, inflammatory change and necrotic tissues 
reparable without any deformities. Therefore, filling in the 
defects of osteonecrosis area by bone cement or bone graft 
substitutes or recovering the local blood supply has been the 
focus[6]. Core decompression could eliminate necrotic bone 
and decrease intraosseous pressure, improve venous return 
and stimulate angiogenesis, thus associated symptoms can 
be relieved and course of disease was shortened. 12 weeks 
after successful establishment of aseptic necrosis of rabbit 
femoral head, compared with blank control group, general 
status of laboratory animals, macroscopic observation, 
osteogenesis and neovascularization were superior in core 
decompression group. Israelite has reported that, after 
long term follow-up visits, the short term and long term 
efficacy of core decompression is satisfactory, which may 
effectively delay the natural progression of osteonecrosis 
at the early stage. Its major disadvantages is that it can’t 
thoroughly repaire the defect of articular cartilage of femoral 
head , mainly attribute to greater defects within the femoral 
head and can’t improve osteogenesis in bone defects, 
especially when there are extensive femoral head necrosis. 
Furthermore, lacking sufficient osteogenesis factors and 
mechanical support structure was another disadvantage of 
core decompression[7].    
  As one of the signaling proteins which has the greatest 
potential for bone induction, rhBMP-2’s bone induction 
properties. It can regulate extracellular matrix not only to 
stimulate chemotaxis of osteoblasts but also to adjust the 
expressions of integrin, thus faster cell proliferation may 
lead to the integration of osteoblasts into extracellular matrix 
and formation of normal, healthy bone tissue[8]. In recent 
years, with the fast development of tissue engineering, the 
treatment strategy of implanting rhBMP-2 into necrotic area 
of femoral head after core decompression could increase 
bone repair in local area, enhance necrotic bone repairing 
and improve the capability of recovery of femoral head 
necrosis. However, it is characterized by short half-life 
period, easy to break down and can’t continuously stimulate 
target cells to give full play to its osteoinductive activity. In 
our study, general status of experimental animals in rhBMP-2 
implantation combined with core decompression group is 
slightly superior to core decompression group 12 weeks after 
operation. However, there are no significant differences in 
regarding macroscopic observation, osteogenesis and new 
blood vessel formation, which may correlate with short half-
life period in vivo, local application and improve local blood 
circulation after core decompression. Therefore it is urgently 
needed to find a kind of suitable carrier to play a maximum 
role in inducing osteoblastic activity as rhBMP-2 can be 
easily washed away by the blood. As an ideal biodegradable 
scaffolds for tissue engineering, PLGA has been widely 
used in the controlled-release drug carriers with good 
biocompatibility, degradability and no immunogenicity, 
which can be used as a promising scaffold for osteogenesis 
factors. PLGA characterized by good biocompatibility and 
without immunoreaction in vivo, could release drugs by 
surface erosion and internal erosion mechanisms in slower 
release rate. As one of the clinically used biodegradable 
materials, PLGA has been approved by FDA to be widely 
used as controlled drug release carriers[9,10]. Surprising 
achievements have been obtained of the application of 
rhBMP-2/PLGA microsphere in controlled drug releasing[5]. 
It is used for local injection after dissolution and is easy 
to operate, thus surgical injuries can be reduced to the 
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minimum extent. Besides, bone formation in the defective 
areas can be enhanced by continuously release rhBMP-2. 
In our study, 12 weeks after operation, the general status 
of laboratory animals, macroscopic observation, bone 
formation and neovascularization of rhBMP-2/PLGA 
group after core decompression treatment were superior 
to those of any other group. The research of Kakudo et al 
focusing on rhBMP-2 inducing mice ectopic endochondral 
ossification shows that there are VEGF expressions in all 
stages of rhBMP-2, which induces bone formation and 
rhBMP-2 may induce undifferentiated stem cells to bone 
cells and cartilage cells. Therefore, the VEGF expression by 
differentiated cells creates favorable blood circulation that 
is beneficial for bone tissue formation[11]. Akeel is in favor 
of the idea that rhBMP-2 increased the expression of VEGF 
by reactive oxygen species[12]. We find that 12 weeks after 
surgery, rhBMP-2/PLGA microsphere implantation group 
after core decompression treatment shows higher VEGF 
expression than any other group, the mechanism of which 
may be the continuously release of rhBMP-2 to induce 
VEGF expressions in the process of bone formation by the 
aid of PLGA microsphere scaffolds. Therefore, expected 
therapeutic efficacy can be achieved by creating favorable 
blood circulation for the recovery of rabbits femoral head 
necrosis. 
  In conclusion, the treatment of rhBMP-2/PLGA sustained 
release microsphere implantation in local area is effective in 
recovering rabbits femoral head necrosis and increases the 
local blood supply to normal level without bone formation 
in defective area after medullary cavity decompression. 
It provides new thoughts for the recovery of femoral head 
necrosis. However, still further studies are needed before 
the clinical application of rhBMP-2/PLGA sustained release 
microsphere.
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